Jim Simons Portage Biotech Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Portage Biotech Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 31,663 shares of PRTG stock, worth $6,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,663
Previous 21,100
50.06%
Holding current value
$6,965
Previous $38,000
52.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PRTG
# of Institutions
27Shares Held
2.16MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.67MShares$366,4940.01% of portfolio
-
Bison Wealth, LLC213KShares$46,9470.02% of portfolio
-
Peak6 Investments LLC Chicago, IL55.3KShares$12,1570.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny32.8KShares$7,2210.0% of portfolio
-
Black Rock Inc. New York, NY31.3KShares$6,8800.0% of portfolio
About PORTAGE BIOTECH INC.
- Ticker PRTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,943,700
- Market Cap $3.73M
- Description
- Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...